Sektor Charles River Laboratories International, Inc. Berne S.E.
Aktien
939391
US1598641074
RV6
Biotechnologie
|
Schlusskurs
Berne S.E.
28.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 243.60 CHF | +0.92% |
|
+6.87% | - |
| 28.09. | Charles River Laboratories International, Inc. : Jefferies & Co. gibt eine Kauf-Bewertung ab | ZM |
| 25.09. | Segment von Charles River Laboratories bietet größtes Margenpotenzial, sagt RBC | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.27% | +3.91% | +1.42% | +8.38% | +8.74% | +12.50% | +37.41% | -16.07% | +216.62% | 49.06 Mrd. | |
| +0.22% | +0.40% | +3.52% | +41.77% | +20.21% | +50.91% | +37.06% | +12.16% | +240.54% | 44.6 Mrd. | |
| -1.58% | +4.66% | -2.95% | +10.80% | +153.28% | +359.34% | +614.38% | +603.91% | - | 43.24 Mrd. | |
| +1.70% | +0.36% | +0.07% | +31.12% | +20.80% | +12.56% | +99.27% | +0.88% | +1’114.03% | 41.73 Mrd. | |
| +0.51% | -1.71% | -6.50% | +7.47% | +3.43% | +5.18% | +46.87% | -17.70% | +133.42% | 29.93 Mrd. | |
| -0.48% | -1.32% | +2.55% | +16.86% | +9.67% | +23.98% | +150.01% | +228.38% | +1’992.19% | 17.19 Mrd. | |
| +0.08% | +9.03% | +32.85% | +51.55% | +44.08% | +8.41% | - | - | - | 15.35 Mrd. | |
| -2.31% | -2.51% | +6.12% | +12.91% | +23.37% | +26.61% | +43.89% | -30.40% | +90.47% | 15.54 Mrd. | |
| +1.97% | -3.17% | -7.20% | -11.77% | - | - | - | - | - | 15.11 Mrd. | |
| +0.60% | +5.58% | +1.06% | +36.54% | +47.68% | +98.30% | +50.83% | -29.47% | +252.59% | 14.06 Mrd. | |
| +1.88% | +3.55% | +3.26% | +3.36% | -3.65% | +7.19% | -28.94% | -33.86% | +127.19% | 13.55 Mrd. | |
| -1.43% | +2.32% | +22.20% | +239.62% | +233.33% | +156.19% | +100.48% | +41.30% | +1’731.86% | 12.21 Mrd. | |
| -0.14% | +0.06% | +0.22% | +2.13% | +23.30% | +39.85% | +6.60% | -40.67% | +166.80% | 11.37 Mrd. | |
| -0.85% | -4.43% | -1.48% | +63.87% | +51.71% | +28.48% | +38.68% | -55.67% | - | 10.86 Mrd. | |
| +0.04% | -4.82% | -5.21% | +3.59% | +43.94% | +99.11% | +683.22% | +84.15% | - | 9.31 Mrd. | |
| +0.41% | -1.75% | -1.31% | +16.87% | +63.09% | +111.27% | +731.52% | +681.35% | +580.23% | 9.22 Mrd. | |
| +1.88% | +0.51% | +4.41% | +14.21% | -4.92% | -2.60% | +1.60% | -21.73% | +42.24% | 9.31 Mrd. | |
| +2.27% | -0.75% | -12.10% | +2.94% | -28.78% | +20.94% | +471.67% | +193.16% | +1’032.76% | 8.31 Mrd. | |
| +1.73% | -4.42% | -17.14% | -12.86% | -3.08% | +444.72% | +1’054.14% | -6.70% | - | 7.98 Mrd. | |
| Durchschnitt | +0.36% | +0.26% | +1.25% | +28.39% | +39.23% | +83.50% | +243.45% | +93.71% | +593.92% | 19.89 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.24% | +1.47% | +1.33% | +25.97% | +41.65% | +82.27% | +190.96% | +103.05% | +543.81% |
- Börse
- Aktien
- 939391 Aktie
- 939391 Aktie
- Sektor Charles River Laboratories International, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
